Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study
- PMID: 35587517
- PMCID: PMC9387719
- DOI: 10.1210/clinem/dgac324
Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study
Abstract
Context: Whether repeated bone mineral density (BMD) screening improves fracture prediction in men is uncertain.
Objective: We evaluated whether a second BMD 7 years after the initial BMD improves fracture prediction in older men.
Methods: Among 3651 community-dwelling men (mean age 79.1 years) with total hip BMD at baseline and Year 7 (Y7), self-reported fractures after Y7 were confirmed by radiographic reports. Fracture prediction assessed using Cox proportional hazards regression and logistic regression with receiver operating characteristic curves for models based on initial BMD, BMD change, and the combination of initial BMD and BMD change (combination model).
Results: During an average follow-up of 8.2 years after Y7, 793 men experienced ≥ 1 clinical fractures, including 426 men with major osteoporotic fractures (MOF) and 193 men with hip fractures. Both initial BMD and BMD change were associated with risk of fracture outcomes independent of each other, but the association was stronger for initial BMD. For example, the multivariable hazard ratio of MOF in the combination model per 1 SD decrement in BMD was 1.76 (95% CI 1.57-1.98) for initial BMD and 1.19 (95% CI 1.08-1.32) for BMD change. Discrimination of fracture outcomes with initial BMD models was somewhat better than with BMD change models and similar to combination models (AUC value for MOF 0.68 [95% CI 0.66-0.71] for initial BMD model, 0.63 [95% CI 0.61-0.66] for BMD change model, and 0.69 [95% CI 0.66-0.71] for combination model).
Conclusion: Repeating BMD after 7 years did not meaningfully improve fracture prediction at the population level in community-dwelling older men.
Keywords: bone mineral density; fracture risk; older men.
Published by Oxford University Press on behalf of the Endocrine Society 2022.
Figures
Comment in
-
How Often Should We Measure Bone Density?J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4267-e4268. doi: 10.1210/clinem/dgac403. J Clin Endocrinol Metab. 2022. PMID: 35776507 No abstract available.
Similar articles
-
Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.JAMA. 2013 Sep 25;310(12):1256-62. doi: 10.1001/jama.2013.277817. JAMA. 2013. PMID: 24065012 Free PMC article.
-
Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.JAMA Intern Med. 2020 Sep 1;180(9):1232-1240. doi: 10.1001/jamainternmed.2020.2986. JAMA Intern Med. 2020. PMID: 32730575 Free PMC article.
-
Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.J Am Med Dir Assoc. 2014 Dec;15(12):918-23. doi: 10.1016/j.jamda.2014.07.011. Epub 2014 Sep 24. J Am Med Dir Assoc. 2014. PMID: 25262197
-
Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.Bone. 2014 Oct;67:10-4. doi: 10.1016/j.bone.2014.06.034. Epub 2014 Jul 2. Bone. 2014. PMID: 24998455
-
Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures.Endocrinol Metab (Seoul). 2020 Mar;35(1):55-63. doi: 10.3803/EnM.2020.35.1.55. Endocrinol Metab (Seoul). 2020. PMID: 32207264 Free PMC article. Review.
Cited by
-
Mapping knowledge structure and global status of sarcopenia in geriatric hip fractures: A bibliometric and visualized study.Front Surg. 2022 Oct 5;9:1019985. doi: 10.3389/fsurg.2022.1019985. eCollection 2022. Front Surg. 2022. PMID: 36277288 Free PMC article.
-
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types.Elife. 2022 Aug 9;11:e76228. doi: 10.7554/eLife.76228. Elife. 2022. PMID: 35942681 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
